These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19077421)

  • 1. Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation.
    Khokhar OS; Farhadi A; McGrail L; Lewis JH
    Chemotherapy; 2009; 55(2):69-75. PubMed ID: 19077421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
    Kohrt HE; Ouyang DL; Keeffe EB
    Clin Liver Dis; 2007 Nov; 11(4):965-91, x. PubMed ID: 17981237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for hepatitis B in chemotherapy patients: survey of current oncology practices.
    Tran TT; Rakoski MO; Martin P; Poordad F
    Aliment Pharmacol Ther; 2010 Jan; 31(2):240-6. PubMed ID: 19814747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients].
    von Wagner M; Zeuzem S
    Dtsch Med Wochenschr; 2009 Feb; 134(6):255-8. PubMed ID: 19180418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
    Mindikoglu AL; Regev A; Schiff ER
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1076-81. PubMed ID: 16861051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.
    Stine JG; Khokhar OS; Charalambopoulos J; Shanmugam VK; Lewis JH
    Arthritis Care Res (Hoboken); 2010 May; 62(5):704-11. PubMed ID: 20461789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
    Coiffier B
    Cancer Invest; 2006; 24(5):548-52. PubMed ID: 16939967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B reactivation in cancer patients: role of prechemotherapy screening and antiviral prophylaxis.
    Kawsar HI; Shahnewaz J; Gopalakrishna KV; Spiro TP; Daw HA
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):370-8. PubMed ID: 22895238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
    Juan J; Feld JJ
    Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of hepatitis B.
    Hoofnagle JH
    Hepatology; 2009 May; 49(5 Suppl):S156-65. PubMed ID: 19399803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
    Koo YX; Tan DS; Tan BH; Quek R; Tao M; Lim ST
    J Clin Oncol; 2009 May; 27(15):2570-1; author reply 2571-2. PubMed ID: 19364951
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
    Zingarelli S; Frassi M; Bazzani C; Scarsi M; Puoti M; Airò P
    J Rheumatol; 2009 Jun; 36(6):1188-94. PubMed ID: 19447932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis.
    Lo Re V; Schuster M
    Ann Intern Med; 2016 Jan; 164(1):64-5. PubMed ID: 26595449
    [No Abstract]   [Full Text] [Related]  

  • 14. [Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir].
    Dumortier J; Durupt S; Chevallier M; Trépo C; Zoulim F
    Gastroenterol Clin Biol; 1997; 21(12):982-6. PubMed ID: 9587563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-viral prophylaxis in inactive hepatitis B virus carriers with hemato-oncological malignancies who receive chemotherapy.
    Idilman R
    Minerva Gastroenterol Dietol; 2006 Mar; 52(1):39-45. PubMed ID: 16554705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management.
    Lubel JS; Testro AG; Angus PW
    Intern Med J; 2007 Oct; 37(10):705-12. PubMed ID: 17894766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B reactivation prophylaxis in immune-suppressed patients.
    Torresin A; Feasi M; Cassola G
    Haematologica; 2008 Nov; 93(11):e65. PubMed ID: 18978291
    [No Abstract]   [Full Text] [Related]  

  • 19. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
    Hammond SP; Borchelt AM; Ukomadu C; Ho VT; Baden LR; Marty FM
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.